Grand Lancy, Switzerland

Sara Majocchi

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sara Majocchi: Innovator in Bispecific Antibodies

Introduction

Sara Majocchi is a prominent inventor based in Grand Lancy, Switzerland. She has made significant contributions to the field of biomedicine, particularly in the development of bispecific antibodies. Her innovative work aims to enhance therapeutic options for various diseases.

Latest Patents

Sara holds a patent for bispecific antibodies against CEACAM5 and CD3. This invention relates to antibodies that bind to human carcinoembryonic antigen CEACAM5 (CEA) and human CD3ε. The patent also encompasses polynucleotides encoding these bispecific antibodies, as well as vectors and host cells that contain such polynucleotides. Furthermore, the invention outlines methods for selecting and producing these antibodies, along with their applications in disease treatment. She has 1 patent to her name.

Career Highlights

Throughout her career, Sara has worked with notable companies, including Lamkap Bio Alpha AG and Lamkap Bio Beta AG. Her expertise in antibody development has positioned her as a key player in the biotechnology sector.

Collaborations

Sara has collaborated with esteemed colleagues, including Klaus Strein and Vanessa Buatois. These partnerships have further enriched her research and innovation efforts.

Conclusion

Sara Majocchi's contributions to the field of bispecific antibodies demonstrate her commitment to advancing medical science. Her innovative spirit and collaborative efforts continue to pave the way for new therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…